Robert Schwarcz, Ph.D.

Printer-friendly versionPrinter-friendly version
Robert Schwarcz, Ph.D.

JOINED THE SCIENTIFIC COUNCIL IN 2009

Professor of Psychiatry, Pharmacology and Pediatrics
Director, Neuroscience Program
Maryland Psychiatric Research Center
University of Maryland

Dr. Schwarcz’s early research focused on molecular and cellular mechanisms underlying neurodegenerative and seizure disorders. He identified a critical role of endogenous neurotoxic agents related to the neurotransmitter glutamate and pioneered the idea that specific antiglutamatergic interventions can prevent nerve cell death. Such neuroprotective strategies may combat catastrophic brain diseases such as Huntington’s disease, Alzheimer’s disease and stroke. More recently, Dr. Schwarcz turned his attention to biological psychiatry, showing that several metabolites of the amino acid tryptophan are substantively involved in the pathophysiology of diseases ranging from major depression to schizophrenia. He and his colleagues are currently exploiting this concept to develop biomarkers and pharmacological treatments.

Dr. Schwarcz received his bachelor’s degree in chemistry as well as his Ph.D. in biochemistry from the University of Vienna, Austria. He has been a faculty

NARSAD Grants: Distinguished Investigator 2002